EUCTR2005-000397-45-GB进行中（未招募）1 期
Randomised Controlled Trial Of Intravitreal Triamcinolone In Patients With Diabetic Macular Oedema Refractory To Laser Treatment
Queen's Medical centre0 个研究点目标入组 40 人开始时间: 2005年3月17日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •All eyes with persistent CSME involving the center of the fovea as judged by slit lamp biomicroscopy and confirmed by active fluorescein leakage on FFA
- •All eyes with previous focal or at least one session of grid laser treatment with the last one being at least 3 months prior to the examaination and deemed to be complete by one of the observers masked to the eventual randomisation -
- •patients could be phakic or pseudophakic
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Excessive ischaemic diabetic maculopathy as judged clinically and/or on fluorescein angiography by >75% destruction of the outline of the foveal avscular zone (FAZ)
- •- patients with large plaques of sub-foveal exudates
- •- patients with active neovascular disease
- •-patients with high blood pressure (> 180/110)
- •-patients with documented renal disease
- •- patients on non steroidal antiinflammatories, systemic prednisolone, methotrexate, diamox. low dose aspirin is not an exclusion criteria and will be allowed on the trial
- •-all patients on warfarin
- •-coexisting glaucoma
- •-history of increased IOP on steroid drops or tablets or ocular hypertension
- •-patients with any other significant ocular pathology affecting the macula eg age related macular degenration
研究者
相似试验
已完成
不适用
Randomised Controlled Trial of Intravitreal Triamcinolone in Patients with Diabetic Macular Oedema Refractory to Laser TreatmentISRCTN90614292Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
招募中
4 期
Prospective study into the effect of an intraocular injection of a steroid in the prevention of Glaucoma drainage surgery failure after cataract surgeryACTRN12611000336987Royal Victorian Eye and Ear110
进行中（未招募）
不适用
Comparison between injections into the eye ( drug Avastin) with 'pretend' injections in diabetic patients in whom no further treatment is currently available in clinic when they have developed swelling of the centre of the macular associated with lack of blood supply.Ischaemic Diabetic Macular OedemaMedDRA version: 14.1Level: LLTClassification code 10057934Term: Diabetic macular edemaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: PTClassification code 10012689Term: Diabetic retinopathySystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: PTClassification code 10012688Term: Diabetic retinal oedemaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: PTClassification code 10012661Term: Diabetic eye diseaseSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: LLTClassification code 10054372Term: Diabetic retinal edemaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: LLTClassification code 10038925Term: Retinopathy diabeticSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: LLTClassification code 10057915Term: Diabetic macular oedemaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: HLTClassification code 10012657Term: Diabetic complications ophthalmicSystem Organ Class: 10014698 - Endocrine disordersMedDRA version: 14.1Level: LLTClassification code 10054109Term: Non-proliferative diabetic retinopathySystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: HLGTClassification code 10012653Term: Diabetic complicationsSystem Organ Class: 10014698 - Endocrine disordersEUCTR2011-003304-20-GBMoorfields Eye Hospital NHS Foundation Trust
尚未招募
不适用
To examine the visual function and thickness of macula to assess function of intravitreal injection of bevacizumab and triamcilone acetonide.CTRI/2020/11/029064Father muller medical college
进行中（未招募）
不适用
Randomised controlled trial of intravitreal Bevacizumab vs. conventional treatment for rubeotic glaucoma. - Randomised controlled trial of intravitreal Bevacizumab vs. conventional treatment for rubeotic glauRubeotic glaucoma secondary to ischaemic proliferative retinopathiesEUCTR2007-000585-21-IERoyal Victoria Eye and Ear hospital20